Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 24;61(6):e02635-16.
doi: 10.1128/AAC.02635-16. Print 2017 Jun.

A New Natural Product Analog of Blasticidin S Reveals Cellular Uptake Facilitated by the NorA Multidrug Transporter

Affiliations

A New Natural Product Analog of Blasticidin S Reveals Cellular Uptake Facilitated by the NorA Multidrug Transporter

Jack R Davison et al. Antimicrob Agents Chemother. .

Abstract

The permeation of antibiotics through bacterial membranes to their target site is a crucial determinant of drug activity but in many cases remains poorly understood. During screening efforts to discover new broad-spectrum antibiotic compounds from marine sponge samples, we identified a new analog of the peptidyl nucleoside antibiotic blasticidin S that exhibited up to 16-fold-improved potency against a range of laboratory and clinical bacterial strains which we named P10. Whole-genome sequencing of laboratory-evolved strains of Staphylococcus aureus resistant to blasticidin S and P10, combined with genome-wide assessment of the fitness of barcoded Escherichia coli knockout strains in the presence of the antibiotics, revealed that restriction of cellular access was a key feature in the development of resistance to this class of drug. In particular, the gene encoding the well-characterized multidrug efflux pump NorA was found to be mutated in 69% of all S. aureus isolates resistant to blasticidin S or P10. Unexpectedly, resistance was associated with inactivation of norA, suggesting that the NorA transporter facilitates cellular entry of peptidyl nucleosides in addition to its known role in the efflux of diverse compounds, including fluoroquinolone antibiotics.

Keywords: antibiotic resistance; chemical genomics; natural products; transporters.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Structures of blasticidin S (1) and P10 (2).
FIG 2
FIG 2
In vitro inhibition of translation by blasticidin S and P10. Translation activity in the presence of antibiotics relative to the expression level in the absence of compounds was determined by expression of a luciferase reporter in an E. coli cell extract. Error bars represent the range of duplicate assays. The positive (chloramphenicol [50 μM]) and negative (DMSO) controls inhibited translation by 99% and 0%, respectively.
FIG 3
FIG 3
Genetic map of the determinants of blasticidin S and P10 resistance in S. aureus. Scaffolds resulting from genomic assembly of the four parent strains of S. aureus are represented in the outer ring, with size marked in kilobases. Mutant strains are displayed in the inner rings and are ordered and colored by the average increase in MIC of blasticidin S and P10 relative to the wild-type levels (strain names are abbreviated such that P10r-1 corresponds to P1). The positions of mutations are marked for each strain, with a square denoting large deletions, a triangle denoting gene inactivations (frameshift or stop codon), and a circle representing the remainder. Dark markers represent unique mutations, while light markers represent identical polymorphisms observed in multiple strains. Gene symbols corresponding to mutations (except deletions) are displayed around the outer side of the assembly track.
FIG 4
FIG 4
The effect of norA on resistance and cellular uptake for blasticidin S (BlaS), P10, and norfloxacin (NOR). (A) Disk diffusion assay showing zones of inhibition surrounding paper disks loaded with antibiotic overlaid on bacterial cultures of S. aureus TCH1516 WT (panel i), TCH1516 P10r-16 (ΔnorA) (panel ii), TCH1516 P10r-16::norA (norA complementation) exposed to blasticidin S (panel iii), TCH1516 WT (panel iv), TCH1516 P10r-16 (panel v), TCH1516 P10r-16::norA exposed to P10 (panel vi), TCH1516 WT (panel vii), TCH1516 P10r-16 (panel viii), and TCH1516 P10r-16::norA exposed to norfloxacin (panel ix). (B) E. coli NEB5α (left panel) and NEB5α::norA (right panel) exposed to blasticidin S (panel i), P10 (panel ii), and norfloxacin (panel iii). (C) Quantitation of the concentration of blasticidin, P10, and norfloxacin in cell lysates of E. coli NEB5α transformed with a control plasmid or the norA gene, exposed to each antibiotic; error bars represent standard deviations of results from three replicates.
FIG 5
FIG 5
The functions of genes associated with significant levels of susceptibility or resistance to blasticidin S (circles) and P10 (triangles). Significant genes were selected with a Padj cutoff value of <0.01. Points are colored according to gene product function (Table S10). The top six most significant hits for P10 with a Padj value of ≪10−8, encoding the subunits and regulator of an ABC superfamily membrane transport complex, were omitted for clarity.

References

    1. Bush K, Courvalin P, Dantas G, Davies J, Eisenstein B, Huovinen P, Jacoby GA, Kishony R, Kreiswirth BN, Kutter E, Lerner SA, Levy S, Lewis K, Lomovskaya O, Miller JH, Mobashery S, Piddock LJV, Projan S, Thomas CM, Tomasz A, Tulkens PM, Walsh TM, Watson JD, Witkowski J, Witte W, Wright G, Yeh P, Zgurskaya HI. 2011. Tackling antibiotic resistance. Nat Rev Microbiol 9:894–896. doi:10.1038/nrmicro2693. - DOI - PMC - PubMed
    1. Theuretzbacher U. 2012. Accelerating resistance, inadequate antibacterial drug pipelines and international responses. Int J Antimicrob Agents 39:295–299. doi:10.1016/j.ijantimicag.2011.12.006. - DOI - PubMed
    1. Perros M. 2015. A sustainable model for antibiotics. Nature 347:1062–1064. doi:10.1126/science.aaa3048. - DOI - PubMed
    1. Li JW-H, Vederas JC. 2009. Drug discovery and natural products: end of an era or an endless frontier? Science 325:161–165. doi:10.1126/science.1168243. - DOI - PubMed
    1. Davies J. 2011. How to discover new antibiotics: harvesting the parvome. Curr Opin Chem Biol 15:5–10. doi:10.1016/j.cbpa.2010.11.001. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources